cell culture

Fujifilm Invests Additional $1.2 Billion in CDMO Business in North Carolina

Fujifilm announced an additional investment of $1.2 billion in its large-scale cell culture contract development and manufacturing organization (CDMO) business to further expand the planned Fujifilm Diosynth Biotechnologies facility in Holly Springs, North Carolina, bringing the total investment in the facility to over $3.2 billion. Plans for the new site were unveiled in September last year.

Fujifilm Diosynth Announces New US Cell Culture Production Facility

Fujifilm Diosynth Biotechnologies unveiled its new $2 billion large-scale cell culture manufacturing facility in Holly Springs, North Carolina, US.

Fujifilm Invests $1.6 Billion for Cell Culture Expansion

Fujifilm is preparing to invest $1.6 billion to ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies.

DSM Opens cGMP Biopharmaceutical Manufacturing Operation in Brisbane, Australia

DSM Announces License Agreement with Amgen

Sartorius, Lonza Announce Collboration on Cell Culture Media

EMD Millipore, Sistemic Collaborate to Identify Control Markers for Stem Cell Production

Lonza, Biowa Sign License Agreements with FivePrime Therapeutics